Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 129.2 CHF -1.82% Market Closed
Market Cap: 2.6B CHF

Intrinsic Value

The intrinsic value of one MOVE stock under the Base Case scenario is 113.34 CHF. Compared to the current market price of 129.2 CHF, Medacta Group SA is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MOVE Intrinsic Value
113.34 CHF
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medacta Group SA

MOVE
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MOVE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Medacta Group SA
SIX:MOVE
CH
Health Care
Market Cap
2.6B CHF
IPO
Apr 4, 2019
CH
Health Care
Market Cap
2.6B CHF
IPO
Apr 4, 2019
Price
CHffalse
EPS
€false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MOVE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Medacta Group SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medacta Group SA

Current Assets 364.3m
Cash & Short-Term Investments 21.7m
Receivables 118.4m
Other Current Assets 224.2m
Non-Current Assets 367.5m
Long-Term Investments 892k
PP&E 291.7m
Intangibles 49.7m
Other Non-Current Assets 25.2m
Efficiency

Free Cash Flow Analysis
Medacta Group SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medacta Group SA

Revenue
544.3m EUR
Cost of Revenue
-174.6m EUR
Gross Profit
369.7m EUR
Operating Expenses
-291.8m EUR
Operating Income
78m EUR
Other Expenses
-21.8m EUR
Net Income
56.2m EUR
Fundamental Scores

MOVE Profitability Score
Profitability Due Diligence

Medacta Group SA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
59/100
Profitability
Score

Medacta Group SA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

MOVE Solvency Score
Solvency Due Diligence

Medacta Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Low D/E
Short-Term Solvency
67/100
Solvency
Score

Medacta Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MOVE Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOVE is 151.16 CHF with a low forecast of 137.36 CHF and a high forecast of 168 CHF.

Lowest
Price Target
137.36 CHF
6% Upside
Average
Price Target
151.16 CHF
17% Upside
Highest
Price Target
168 CHF
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MOVE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MOVE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MOVE stock?

The intrinsic value of one MOVE stock under the Base Case scenario is 113.34 CHF.

Is MOVE stock undervalued or overvalued?

Compared to the current market price of 129.2 CHF, Medacta Group SA is Overvalued by 12%.

Back to Top